Andrew Saik
2018 - Edge Therapeutics
In 2018, Andrew Saik earned a total compensation of $1.3M as Chief Financial Officer at Edge Therapeutics, a 23% decrease compared to previous year.
Compensation breakdown
| Bonus | $166,500 |
|---|---|
| Option Awards | $660,490 |
| Salary | $370,000 |
| Stock Awards | $70,632 |
| Total | $1,267,622 |
Saik received $660.5K in option awards, accounting for 52% of the total pay in 2018.
Saik also received $166.5K in bonus, $370K in salary and $70.6K in stock awards.
Rankings
In 2018, Andrew Saik's compensation ranked 8,008th out of 14,244 executives tracked by ExecPay. In other words, Saik earned more than 43.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,008 out of 14,244 | 44th |
Division Manufacturing | 3,149 out of 5,765 | 45th |
Major group Chemicals And Allied Products | 1,174 out of 2,128 | 45th |
Industry group Drugs | 986 out of 1,817 | 46th |
Industry Pharmaceutical Preparations | 766 out of 1,391 | 45th |
Source: SEC filing on August 15, 2019.
Saik's colleagues
We found four more compensation records of executives who worked with Andrew Saik at Edge Therapeutics in 2018.